SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM)

BACKGROUND & OBJECTIVE: Sodium glucose co-transporter-2 inhibitors (SGLT 2 inhibitors) are newer anti-hyperglycemic agents, which improve glycemic control independent of insulin secretion with a low risk of hypoglycemia. This study aimed to assess the efficacy of SGLT 2 inhibitors in terms of gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohail, Erum, Ahsan, Tasnim, Ghaus, Saima, Aijaz, Wasfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794133/
https://www.ncbi.nlm.nih.gov/pubmed/33437256
http://dx.doi.org/10.12669/pjms.37.1.2701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794133/
https://www.ncbi.nlm.nih.gov/pubmed/33437256
http://dx.doi.org/10.12669/pjms.37.1.2701

Ejemplares similares